Iridex Launches New Iridex 532® and Iridex 577® Lasers in US Market Marking 35 Years of Laser Innovation in Treating Retina Disorders & Glaucoma
January 11, 2024 18:45 ET
|
IRIDEX Corporation
MOUNTAIN VIEW, Calif., Jan. 11, 2024 (GLOBE NEWSWIRE) -- Iridex Corporation, a global leader in innovative laser-based medical systems for the treatment of eye diseases, proudly announces the US...
Eye Melanoma Market Size Worth USD 9.56 Billion in 2032 | Emergen Research
January 11, 2024 08:57 ET
|
Emergen Research
Vancouver, Jan. 11, 2024 (GLOBE NEWSWIRE) -- The global eye melanoma market size was USD 4.35 billion in 2022 and is expected to register a revenue CAGR of 8.3% during the forecast period. Eye...
Global Pupillometer Market Forecast: Surge in Digital and Hand-Held Types, Focus on Ophthalmology Applications
January 10, 2024 20:33 ET
|
Research and Markets
Dublin, Jan. 10, 2024 (GLOBE NEWSWIRE) -- The "Global Pupillometer Market by Mobility (Hand-Held, Table-Top), Type (Digital, Video), Application, End-Use - Forecast 2023-2030" report has been added...
Vitrectomy Devices Market Reaches USD 1.94 Billion in 2023 and Expected to Surge at 14.55% CAGR to USD 5.06 Billion by 2030
January 10, 2024 20:18 ET
|
Research and Markets
Dublin, Jan. 10, 2024 (GLOBE NEWSWIRE) -- The "Global Vitrectomy Devices Market by Product (Illumination Devices, Photocoagulation Lasers, Vitrectomy Machines), Surgery (Anterior Vitreoretinal...
Novartis' Cosentyx Shows Promising Early Progress in Treating Hidradenitis Suppurativa, Poised for Significant Future Adoption at the Expense of AbbVie's Humira
January 10, 2024 15:58 ET
|
Spherix Global Insights
Exton, Pennsylvania, Jan. 10, 2024 (GLOBE NEWSWIRE) -- In late October 2023, the FDA granted approval to Novartis' Cosentyx (secukinumab) for treating hidradenitis suppurativa (HS), marking it as...
Orthokeratology Lens Market Forecasts from 2023 to 2028 - Opportunities Amid Rising Refractive Error Prevalence
January 10, 2024 11:18 ET
|
Research and Markets
Dublin, Jan. 10, 2024 (GLOBE NEWSWIRE) -- The "Orthokeratology Lens Market Forecasts from 2023 to 2028" report has been added to ResearchAndMarkets.com's offering.There is an increasing prevalence...
Alkeus Pharmaceuticals Presents Positive Interim Data Showing Gildeuretinol Halted Stargardt Disease Progression
January 10, 2024 06:00 ET
|
Alkeus Pharmaceuticals
All three patients treated for two years or more have remained free of symptoms and disease progression while taking gildeuretinol.TEASE-3 is the first clinical trial in early-stage Stargardt disease,...
iSTAR Medical Expands International Commercial Rollout of MINIject® with Successful First Implants Completed in Australia
January 10, 2024 03:00 ET
|
iSTAR Medical
For immediate release iSTAR Medical Expands International Commercial Rollout of MINIject® with Successful First Implants Completed in Australia WAVRE, Belgium — 10 January 2024: iSTAR Medical, a...
Optical Coherence Tomography in Ophthalmology Market Forecast: Significant Growth Predicted with Rising CAGR of 17.12% by 2030
January 09, 2024 16:33 ET
|
Research and Markets
Dublin, Jan. 09, 2024 (GLOBE NEWSWIRE) -- The "Global Optical Coherence Tomography for Ophthalmology Market by Product (Catheter-based OCT Devices, Doppler OCT Devices, Handheld OCT Devices), Type...
Cross Keys Capital Advises Bucks-Mont Eye Associates, P.C., in its Partnership with Vision Innovation Partners
January 09, 2024 08:00 ET
|
Cross Keys Capital, LLC.
Fort Lauderdale, Jan. 09, 2024 (GLOBE NEWSWIRE) -- Cross Keys Capital Healthcare (Cross Keys), a leading independent investment banking firm providing M&A advisory services to physician group...